| scholarly article | Q13442814 |
| P50 | author | Flossie Wong-Staal | Q3074353 |
| P2093 | author name string | Li X | |
| Kang D | |||
| Ho AD | |||
| Gervaix A | |||
| Law P | |||
| Spector SA | |||
| P2860 | cites work | Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells | Q43752706 |
| P433 | issue | 2 | |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 233-239 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies | |
| P478 | volume | 5 |
| Q41783724 | Anti-HBV hairpin ribozyme-mediated cleavage of target RNA in vitro |
| Q36555327 | Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model |
| Q45890110 | Expression of ribozymes in gene transfer systems to modulate target RNA levels |
| Q40739621 | Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense |
| Q33851112 | Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev |
| Q34010283 | Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis |
| Q45865707 | Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro |
| Q34234190 | Ribozyme gene therapy: applications for molecular medicine |
| Q34062644 | Ribozyme therapy for HIV infection |
| Q33751872 | Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function. |
| Q33770594 | The hairpin ribozyme. Discovery, mechanism, and development for gene therapy |
Search more.